C12N 2710/00033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2710/00033 (Use of viral protein as therapeutic agent other than vaccine) appears on 17 US grants and 19 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 19
- Assignees
- 2
- Inventors
- 12
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 3 |
| 2017 | 2 | 2 |
| 2018 | 3 | 2 |
| 2019 | 2 | 1 |
| 2020 | 2 | 2 |
| 2021 | 3 | 2 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 3 | 1 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Chimeric protein toxins for expression by therapeutic bacteria2 Jun 2026US 12,642,873 B1
- RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci20 Aug 2024US 12,065,668 B2The General Hospital Corporation
- Increasing specificity for RNA-guided genome editing5 Mar 2024US 11,920,152 B2The General Hospital Corporation
- Systems and methods for increasing efficiency of genome editing16 Jan 2024US 11,873,322 B2Yeda Research and Development Co. Ltd.
- Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing25 Apr 2023US 11,634,731 B2The General Hospital Corporation
- Inhibition of neuronal activity by means of potassium ion channels17 Apr 2025US 2025/0122261 A1
- RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci30 Jan 2025US 2025/0034597 A1The General Hospital Corporation
- Increasing Specificity for RNA-Guided Genome Editing18 Jul 2024US 2024/0240207 A1The General Hospital Corporation
- Using Truncated Guide RNAs (tru-gRNAs) to Increase Specificity for RNA-Guided Genome Editing21 Dec 2023US 2023/0407341 A1The General Hospital Corporation
- RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci24 Mar 2022US 2022/0090145 A1The General Hospital Corporation
Most cited
By later US patents
- Increasing specificity for RNA-guided genome editing95US 9,885,033 B2The General Hospital Corporation · 2018
- Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing87US 9,567,604 B2The General Hospital Corporation · 2017
- Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing85US 9,567,603 B2The General Hospital Corporation · 2017
- Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing43US 10,415,059 B2The General Hospital Corporation · 2019
- Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing39US 10,119,133 B2The General Hospital Corporation · 2018